|
1
|
<?xml version="1.0" encoding="UTF-8" standalone="yes"?>
|
|
2
|
<ns2:regimens xmlns:ns2="http://www.msh.org/quantb/model/regimen">
|
|
3
|
<ns2:regimen>
|
|
4
|
<name>2(HRZE)/4(HR) - (weight 40 -54kg)</name>
|
|
5
|
<intensive>
|
|
6
|
<medications>
|
|
7
|
<medicine>
|
|
8
|
<name>4FDC (75/150/400/275)</name>
|
|
9
|
<abbrevName>HRZE (75/150/400/275)</abbrevName>
|
|
10
|
<strength>75+150+400+275mg</strength>
|
|
11
|
<dosage>Tablet</dosage>
|
|
12
|
</medicine>
|
|
13
|
<duration>2</duration>
|
|
14
|
<dosage>3</dosage>
|
|
15
|
<daysPerWeek>7</daysPerWeek>
|
|
16
|
</medications>
|
|
17
|
</intensive>
|
|
18
|
<continious>
|
|
19
|
<medications>
|
|
20
|
<medicine>
|
|
21
|
<name>2FDC - HR(75/150)</name>
|
|
22
|
<abbrevName>HR (75/150)</abbrevName>
|
|
23
|
<strength>75+150mg</strength>
|
|
24
|
<dosage>Tablet</dosage>
|
|
25
|
</medicine>
|
|
26
|
<duration>4</duration>
|
|
27
|
<dosage>3</dosage>
|
|
28
|
<daysPerWeek>7</daysPerWeek>
|
|
29
|
</medications>
|
|
30
|
</continious>
|
|
31
|
<formulation></formulation>
|
|
32
|
</ns2:regimen>
|
|
33
|
<ns2:regimen>
|
|
34
|
<name>2(HR)ZE/4(HR) - (weight 40 -54kg)</name>
|
|
35
|
<intensive>
|
|
36
|
<medications>
|
|
37
|
<medicine>
|
|
38
|
<name>Ethambutol</name>
|
|
39
|
<abbrevName>E (400)</abbrevName>
|
|
40
|
<strength>400 mg</strength>
|
|
41
|
<dosage>Tablet</dosage>
|
|
42
|
</medicine>
|
|
43
|
<duration>2</duration>
|
|
44
|
<dosage>2</dosage>
|
|
45
|
<daysPerWeek>7</daysPerWeek>
|
|
46
|
</medications>
|
|
47
|
<medications>
|
|
48
|
<medicine>
|
|
49
|
<name>2FDC - HR(75/150)</name>
|
|
50
|
<abbrevName>HR (75/150)</abbrevName>
|
|
51
|
<strength>75+150mg</strength>
|
|
52
|
<dosage>Tablet</dosage>
|
|
53
|
</medicine>
|
|
54
|
<duration>2</duration>
|
|
55
|
<dosage>3</dosage>
|
|
56
|
<daysPerWeek>7</daysPerWeek>
|
|
57
|
</medications>
|
|
58
|
<medications>
|
|
59
|
<medicine>
|
|
60
|
<name>Pyrazinamide</name>
|
|
61
|
<abbrevName>Z (400)</abbrevName>
|
|
62
|
<strength>400mg</strength>
|
|
63
|
<dosage>Tablet</dosage>
|
|
64
|
</medicine>
|
|
65
|
<duration>2</duration>
|
|
66
|
<dosage>3</dosage>
|
|
67
|
<daysPerWeek>7</daysPerWeek>
|
|
68
|
</medications>
|
|
69
|
</intensive>
|
|
70
|
<continious>
|
|
71
|
<medications>
|
|
72
|
<medicine>
|
|
73
|
<name>2FDC - HR(75/150)</name>
|
|
74
|
<abbrevName>HR (75/150)</abbrevName>
|
|
75
|
<strength>75+150mg</strength>
|
|
76
|
<dosage>Tablet</dosage>
|
|
77
|
</medicine>
|
|
78
|
<duration>4</duration>
|
|
79
|
<dosage>3</dosage>
|
|
80
|
<daysPerWeek>7</daysPerWeek>
|
|
81
|
</medications>
|
|
82
|
</continious>
|
|
83
|
<formulation></formulation>
|
|
84
|
</ns2:regimen>
|
|
85
|
<ns2:regimen>
|
|
86
|
<name>MDR-TB Regimen 1 (weight 51-70kg)</name>
|
|
87
|
<intensive>
|
|
88
|
<medications>
|
|
89
|
<medicine>
|
|
90
|
<name>Capreomicin</name>
|
|
91
|
<abbrevName>Cm (1000)</abbrevName>
|
|
92
|
<strength>1000 mg</strength>
|
|
93
|
<dosage>Powder/Vial</dosage>
|
|
94
|
</medicine>
|
|
95
|
<duration>8</duration>
|
|
96
|
<dosage>1</dosage>
|
|
97
|
<daysPerWeek>6</daysPerWeek>
|
|
98
|
</medications>
|
|
99
|
<medications>
|
|
100
|
<medicine>
|
|
101
|
<name>Cycloserine</name>
|
|
102
|
<abbrevName>Cs (250)</abbrevName>
|
|
103
|
<strength>250 mg</strength>
|
|
104
|
<dosage>Tablet or Capsule</dosage>
|
|
105
|
</medicine>
|
|
106
|
<duration>8</duration>
|
|
107
|
<dosage>3</dosage>
|
|
108
|
<daysPerWeek>6</daysPerWeek>
|
|
109
|
</medications>
|
|
110
|
<medications>
|
|
111
|
<medicine>
|
|
112
|
<name>Prothionamide </name>
|
|
113
|
<abbrevName>Pto (250)</abbrevName>
|
|
114
|
<strength>250mg</strength>
|
|
115
|
<dosage>Tablet</dosage>
|
|
116
|
</medicine>
|
|
117
|
<duration>8</duration>
|
|
118
|
<dosage>3</dosage>
|
|
119
|
<daysPerWeek>6</daysPerWeek>
|
|
120
|
</medications>
|
|
121
|
<medications>
|
|
122
|
<medicine>
|
|
123
|
<name>Levofloxacin</name>
|
|
124
|
<abbrevName>Lfx (250)</abbrevName>
|
|
125
|
<strength>250mg</strength>
|
|
126
|
<dosage>Tablet</dosage>
|
|
127
|
</medicine>
|
|
128
|
<duration>8</duration>
|
|
129
|
<dosage>3</dosage>
|
|
130
|
<daysPerWeek>6</daysPerWeek>
|
|
131
|
</medications>
|
|
132
|
<medications>
|
|
133
|
<medicine>
|
|
134
|
<name>Pyrazinamide</name>
|
|
135
|
<abbrevName>Z (500)</abbrevName>
|
|
136
|
<strength>500 mg</strength>
|
|
137
|
<dosage>Tablet</dosage>
|
|
138
|
</medicine>
|
|
139
|
<duration>8</duration>
|
|
140
|
<dosage>4</dosage>
|
|
141
|
<daysPerWeek>6</daysPerWeek>
|
|
142
|
</medications>
|
|
143
|
</intensive>
|
|
144
|
<continious>
|
|
145
|
<medications>
|
|
146
|
<medicine>
|
|
147
|
<name>Cycloserine</name>
|
|
148
|
<abbrevName>Cs (250)</abbrevName>
|
|
149
|
<strength>250 mg</strength>
|
|
150
|
<dosage>Tablet or Capsule</dosage>
|
|
151
|
</medicine>
|
|
152
|
<duration>14</duration>
|
|
153
|
<dosage>3</dosage>
|
|
154
|
<daysPerWeek>6</daysPerWeek>
|
|
155
|
</medications>
|
|
156
|
<medications>
|
|
157
|
<medicine>
|
|
158
|
<name>Prothionamide </name>
|
|
159
|
<abbrevName>Pto (250)</abbrevName>
|
|
160
|
<strength>250mg</strength>
|
|
161
|
<dosage>Tablet</dosage>
|
|
162
|
</medicine>
|
|
163
|
<duration>14</duration>
|
|
164
|
<dosage>3</dosage>
|
|
165
|
<daysPerWeek>6</daysPerWeek>
|
|
166
|
</medications>
|
|
167
|
<medications>
|
|
168
|
<medicine>
|
|
169
|
<name>Levofloxacin</name>
|
|
170
|
<abbrevName>Lfx (250)</abbrevName>
|
|
171
|
<strength>250mg</strength>
|
|
172
|
<dosage>Tablet</dosage>
|
|
173
|
</medicine>
|
|
174
|
<duration>14</duration>
|
|
175
|
<dosage>3</dosage>
|
|
176
|
<daysPerWeek>6</daysPerWeek>
|
|
177
|
</medications>
|
|
178
|
<medications>
|
|
179
|
<medicine>
|
|
180
|
<name>Pyrazinamide</name>
|
|
181
|
<abbrevName>Z (500)</abbrevName>
|
|
182
|
<strength>500 mg</strength>
|
|
183
|
<dosage>Tablet</dosage>
|
|
184
|
</medicine>
|
|
185
|
<duration>14</duration>
|
|
186
|
<dosage>4</dosage>
|
|
187
|
<daysPerWeek>6</daysPerWeek>
|
|
188
|
</medications>
|
|
189
|
</continious>
|
|
190
|
<formulation>8CmCsLfxPtoZ/14CsLfxPtoZ</formulation>
|
|
191
|
</ns2:regimen>
|
|
192
|
<ns2:regimen>
|
|
193
|
<name>MDR-TB Regimen 2 (weight 51-70kg)</name>
|
|
194
|
<intensive>
|
|
195
|
<medications>
|
|
196
|
<medicine>
|
|
197
|
<name>Ethionamide</name>
|
|
198
|
<abbrevName>Eto (250)</abbrevName>
|
|
199
|
<strength>250 mg</strength>
|
|
200
|
<dosage>Tablet</dosage>
|
|
201
|
</medicine>
|
|
202
|
<duration>8</duration>
|
|
203
|
<dosage>3</dosage>
|
|
204
|
<daysPerWeek>6</daysPerWeek>
|
|
205
|
</medications>
|
|
206
|
<medications>
|
|
207
|
<medicine>
|
|
208
|
<name>Kanamycin</name>
|
|
209
|
<abbrevName>Km (1000)</abbrevName>
|
|
210
|
<strength>1000 mg</strength>
|
|
211
|
<dosage>Powder/Vial</dosage>
|
|
212
|
</medicine>
|
|
213
|
<duration>8</duration>
|
|
214
|
<dosage>1</dosage>
|
|
215
|
<daysPerWeek>6</daysPerWeek>
|
|
216
|
</medications>
|
|
217
|
<medications>
|
|
218
|
<medicine>
|
|
219
|
<name>Levofloxacin</name>
|
|
220
|
<abbrevName>Lfx (250)</abbrevName>
|
|
221
|
<strength>250mg</strength>
|
|
222
|
<dosage>Tablet</dosage>
|
|
223
|
</medicine>
|
|
224
|
<duration>8</duration>
|
|
225
|
<dosage>3</dosage>
|
|
226
|
<daysPerWeek>6</daysPerWeek>
|
|
227
|
</medications>
|
|
228
|
<medications>
|
|
229
|
<medicine>
|
|
230
|
<name>P-aminosalicylate sodium salt</name>
|
|
231
|
<abbrevName>PAS (Na)</abbrevName>
|
|
232
|
<strength>4000mg</strength>
|
|
233
|
<dosage>Powder/Sachet</dosage>
|
|
234
|
</medicine>
|
|
235
|
<duration>8</duration>
|
|
236
|
<dosage>2</dosage>
|
|
237
|
<daysPerWeek>6</daysPerWeek>
|
|
238
|
</medications>
|
|
239
|
<medications>
|
|
240
|
<medicine>
|
|
241
|
<name>Pyrazinamide</name>
|
|
242
|
<abbrevName>Z (500)</abbrevName>
|
|
243
|
<strength>500 mg</strength>
|
|
244
|
<dosage>Tablet</dosage>
|
|
245
|
</medicine>
|
|
246
|
<duration>8</duration>
|
|
247
|
<dosage>4</dosage>
|
|
248
|
<daysPerWeek>6</daysPerWeek>
|
|
249
|
</medications>
|
|
250
|
</intensive>
|
|
251
|
<continious>
|
|
252
|
<medications>
|
|
253
|
<medicine>
|
|
254
|
<name>Ethionamide</name>
|
|
255
|
<abbrevName>Eto (250)</abbrevName>
|
|
256
|
<strength>250 mg</strength>
|
|
257
|
<dosage>Tablet</dosage>
|
|
258
|
</medicine>
|
|
259
|
<duration>14</duration>
|
|
260
|
<dosage>3</dosage>
|
|
261
|
<daysPerWeek>6</daysPerWeek>
|
|
262
|
</medications>
|
|
263
|
<medications>
|
|
264
|
<medicine>
|
|
265
|
<name>Levofloxacin</name>
|
|
266
|
<abbrevName>Lfx (250)</abbrevName>
|
|
267
|
<strength>250mg</strength>
|
|
268
|
<dosage>Tablet</dosage>
|
|
269
|
</medicine>
|
|
270
|
<duration>14</duration>
|
|
271
|
<dosage>3</dosage>
|
|
272
|
<daysPerWeek>6</daysPerWeek>
|
|
273
|
</medications>
|
|
274
|
<medications>
|
|
275
|
<medicine>
|
|
276
|
<name>P-aminosalicylate sodium salt</name>
|
|
277
|
<abbrevName>PAS (Na)</abbrevName>
|
|
278
|
<strength>4000mg</strength>
|
|
279
|
<dosage>Powder/Sachet</dosage>
|
|
280
|
</medicine>
|
|
281
|
<duration>14</duration>
|
|
282
|
<dosage>2</dosage>
|
|
283
|
<daysPerWeek>6</daysPerWeek>
|
|
284
|
</medications>
|
|
285
|
<medications>
|
|
286
|
<medicine>
|
|
287
|
<name>Pyrazinamide</name>
|
|
288
|
<abbrevName>Z (500)</abbrevName>
|
|
289
|
<strength>500 mg</strength>
|
|
290
|
<dosage>Tablet</dosage>
|
|
291
|
</medicine>
|
|
292
|
<duration>14</duration>
|
|
293
|
<dosage>4</dosage>
|
|
294
|
<daysPerWeek>6</daysPerWeek>
|
|
295
|
</medications>
|
|
296
|
</continious>
|
|
297
|
<formulation>8KmLfxEtoPASZ/14LfxEtoPASZ</formulation>
|
|
298
|
</ns2:regimen>
|
|
299
|
<ns2:regimen>
|
|
300
|
<name>Single Drug 1</name>
|
|
301
|
<intensive>
|
|
302
|
<medications>
|
|
303
|
<medicine>
|
|
304
|
<name>Amikacin</name>
|
|
305
|
<abbrevName>Am (500/2)</abbrevName>
|
|
306
|
<strength>500mg/2ml</strength>
|
|
307
|
<dosage>Vial</dosage>
|
|
308
|
</medicine>
|
|
309
|
<duration>6</duration>
|
|
310
|
<dosage>1</dosage>
|
|
311
|
<daysPerWeek>3</daysPerWeek>
|
|
312
|
</medications>
|
|
313
|
</intensive>
|
|
314
|
<continious/>
|
|
315
|
<formulation>Am</formulation>
|
|
316
|
</ns2:regimen>
|
|
317
|
<ns2:regimen>
|
|
318
|
<name>Single Drug 2</name>
|
|
319
|
<intensive>
|
|
320
|
<medications>
|
|
321
|
<medicine>
|
|
322
|
<name>Cycloserine</name>
|
|
323
|
<abbrevName>Cs (250)</abbrevName>
|
|
324
|
<strength>250 mg</strength>
|
|
325
|
<dosage>Tablet or Capsule</dosage>
|
|
326
|
</medicine>
|
|
327
|
<duration>9</duration>
|
|
328
|
<dosage>2</dosage>
|
|
329
|
<daysPerWeek>7</daysPerWeek>
|
|
330
|
</medications>
|
|
331
|
</intensive>
|
|
332
|
<continious/>
|
|
333
|
<formulation>Cs</formulation>
|
|
334
|
</ns2:regimen>
|
|
335
|
<ns2:regimen>
|
|
336
|
<name>Single Drug 3</name>
|
|
337
|
<intensive>
|
|
338
|
<medications>
|
|
339
|
<medicine>
|
|
340
|
<name>Pyrazinamide</name>
|
|
341
|
<abbrevName>Z (500)</abbrevName>
|
|
342
|
<strength>500 mg</strength>
|
|
343
|
<dosage>Tablet</dosage>
|
|
344
|
</medicine>
|
|
345
|
<duration>12</duration>
|
|
346
|
<dosage>4</dosage>
|
|
347
|
<daysPerWeek>7</daysPerWeek>
|
|
348
|
</medications>
|
|
349
|
</intensive>
|
|
350
|
<continious/>
|
|
351
|
<formulation>Z</formulation>
|
|
352
|
</ns2:regimen>
|
|
353
|
<ns2:stamp name="USER">
|
|
354
|
<lastUpdated>2013-07-19T16:53:09.561-04:00</lastUpdated>
|
|
355
|
</ns2:stamp>
|
|
356
|
</ns2:regimens>
|